Enterprise Value
26.92M
Cash
4.084M
Avg Qtr Burn
-5.62M
Short % of Float
0.04%
Insider Ownership
52.30%
Institutional Own.
2.91%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
HCW9218 Details Cancer, Solid tumor/s, Ovarian cancer | Phase 2 Initiation | |
HCW9218 Details Solid tumor/s, Cancer, Pancreatic cancer | Phase 1/2 Data readout | |
HCW9302 Details Autoimmune disease | IND Submission |